Skip to main content

Table 1 RNA yield and quality before and after DNase I treatment

From: I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice

Samples before Dnase I treatment OD260 OD280 OD260/ OD280 RNA concentration(ng/μl)
IVBD-1 17.079 8.765 1.95 683.14
IVBD-2 15.494 7.962 1.95 619.77
IVBD-3 5.603 3.829 1.46 224.11
IVBD-4 11.815 5.889 2.01 472.58
IVBD-5 17.626 8.540 2.06 705.05
Control-1 13.908 7.215 1.93 556.32
Control-2 9.294 4.841 1.92 371.75
Control-3 11.153 5.965 1.87 446.14
Control-4 14.234 7.344 1.94 569.36
Control-5 14.797 7.684 1.93 591.89
Samples after DNase I treatment OD 260 OD 280 OD 260 / OD 280 RNA concentration(ng/ul)
IVBD-1 7.994 3.939 2.03 319.76
IVBD-2 6.840 3.493 1.96 273.59
IVBD-3 5.417 2.769 1.96 216.68
IVBD-4 8.579 4.371 1.96 343.16
IVBD-5 12.352 6.073 2.03 494.08
Control-1 4.455 2.307 1.93 178.20
Control-2 4.807 2.405 2.00 192.27
Control-3 10.141 5.244 1.93 405.63
Control-4 10.424 5.408 1.93 416.96
  1. IVBD, ivabradine.